425PSPIRE: A phase Ib/ randomised IIa open label clinical trial combining guadecitabine with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer. (23rd October 2018) - Crabb, S J; Danson, S J; Dunkley, D; Kalevras, M; Whitehead, A; Hill, S; Fines, K; Robb, C; Bennett, J; Ksiazek, L; Brown, S L; Evans, L; et al.